Baird lowered the firm’s price target on Waters (WAT) to $363 from $398 and keeps an Outperform rating on the shares. The firm updated its model following Q4 results and the closing of the BD deal.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT:
- Waters price target lowered to $373 from $400 at TD Cowen
- Waters resumed with an In Line at Evercore ISI
- Maintaining Hold on Waters as BD Life Sciences Weakness and Reduced Premium Valuation Temper Near‑Term Upside
- Waters price target lowered to $350 from $410 at BofA
- Waters reinstated with an Overweight at Barclays